Essepna 0.5 g (Isoleucine SOLUTION) 0.5 G

ESSEPNA 0.5 G is an intravenous solution containing isoleucine, an essential amino acid. It is used to support nutritional needs in clinical settings. This product is manufactured by Fresenius Kabi Canada Ltd.

Strength

0.5 G

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

ESSEPNA 0.5 G is primarily used to provide essential amino acids to patients who cannot meet their nutritional needs through oral intake. Isoleucine, the active ingredient, plays a crucial role in protein synthesis and muscle metabolism. This solution is often administered in hospital settings to support patients undergoing certain medical treatments or recovering from surgery.

Side Effects

When administered intravenously, ESSEPNA 0.5 G delivers isoleucine directly into the bloodstream. This can help maintain adequate levels of essential amino acids, which are vital for various bodily functions. Patients may experience improved nutritional status and support for muscle health.

Precautions & Warnings

ESSEPNA 0.5 G should be used under medical supervision. It is important to follow the prescribed administration guidelines to avoid potential complications. Patients with known allergies to any of the ingredients should consult their healthcare provider before use.

Avoid Interactions

ESSEPNA 0.5 G may interact with other medications or supplements. It is advisable to inform your healthcare provider about all current medications to avoid potential interactions. Always follow the advice of a healthcare professional regarding the use of this solution.

Frequently Asked Questions

ESSEPNA 0.5 G is used to provide essential amino acids to patients who cannot meet their nutritional needs through oral intake.

ESSEPNA 0.5 G is administered intravenously under medical supervision.

ESSEPNA 0.5 G delivers isoleucine directly into the bloodstream, supporting protein synthesis and muscle metabolism.

ESSEPNA 0.5 G should be used under medical supervision, and patients with allergies should consult their healthcare provider.

ESSEPNA 0.5 G may interact with other medications, so it is important to inform your healthcare provider about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.